Atomic AI’s ATOM-1 large language model (LLM) demonstrates state-of-the-art accuracy for predicting RNA structure and function Technology can be exp...
OmniAb, Inc. announces the presentation of new scientific data on its OmnidAb™ platform, the industry’s first and only transgenic chicken...
Roivant (Nasdaq: ROIV) announced the completion of the previously announced acquisition by Roche (SIX: RO, ROG; OTCQX: RHHBY) of Telavant, for an upf...
Novozymes and Chr. Hansen announced their future name ‘Novonesis’. The name reflects the beginning of an era of biosolutions where Novonesis wi...
AstraZeneca has entered into a definitive agreement to acquire Icosavax, Inc. (NASDAQ: ICVX), a US-based clinical-stage biopharmaceutical company focused o...
CELLphenomics’ PD3D® tumor model platform will expand Charles River’s portfolio of 3D in vitro testing services Charles Rive...
Bayesian optimization engine that already powers dozens of use cases at Merck now open sourced to foster adoption Close partnership to enable the self-d...
With personalized, data-driven recommendations delivered through mobile applications, the partners provide consumers with tips, recommendations, and motiva...
Details strong pipeline including Sanofi’s record 12 blockbuster opportunities under clinical evaluation: 9 innovative medicines and vaccines with ...
As a result, Vetter has committed to the 1.5 degrees of global warming target. To this end, the CDMO has presented a sustainability strategy with concrete ...
Results from the EVOLUTION clinical trials showed evobrutinib did not meet its primary endpoint of annualized relapse rate for up to 156 weeks compared to ...
“India’s Bioeconomy witnessed double digit growth rate year-on-year in the last 9/10 years under the leadership of Prime Minister Shri Narend...
Pimicotinib (ABSK021) is currently in a global Phase III study in tenosynovial giant cell tumor (TGCT) Merck to receive an exclusive commercial license ...
The two organizations published a joint abstract, “Experimental demonstration of 360nA FLASH proton beam current via synchrocyclotron using IBA Prote...
© 2025 Biopharma Boardroom. All Rights Reserved.
